Zealand Pharma Chief Medical Officer sells shares worth USD 650,000
![Adam Steensberg, Chief Medical Officer and Head of Research and Development | Photo: Zealand Pharma](https://photos.watchmedier.dk/watchmedier/resize:fill:3840:0:0/plain/https://photos.watchmedier.dk/Images/article13250346.ece/ALTERNATES/schema-16_9/doc7hd775b88bph3g8o4hn.jpg)
Zealand Pharma’s Head of Research and Development Adam Steensberg has sold shares worth USD 655,000 (DKK 4.1m), the company reports in a statement.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
Get full access for you and your coworkers
Start a free company trial todayRelated articles
Zealand Pharma CEO: Zegalogue launch continues as planned
For subscribers
Zealand Pharma CEO: "A very busy time for us"
For subscribers